RosofBD. The Worst Loss: How Families Heal From the Death of a Child. New York Henry Holt and Co, 1994.
2.
MulhearnRK, LauerME, HoffmannRG. Death of a child at home or in the hospital: subsequent psychological adjustment of the family. Pediatrics1983; 71 (5):743–747.
3.
MartinsonIM, ArmstrongGD, GeisDP, AnglimMA, GronsethEC, MacInnisH, KerseyJH, NesbitME. Home care for children dying of cancer. Pediatrics1978; 62 (1):106–113.
4.
LevetownM.Barriers to Pediatric Palliative Care: Results of a National Survey, unpublished. Presented at the Academy of Hospice Physicians annual meeting, Vancouver, British Columbia, 1995.
5.
Guidelines for the Determination of Terminal Illness in Non-Cancer Patients. Arlington, Virginia: National Hospice Organization, 1995.
6.
FischerAF, StevensonDK. The consequences of uncertainty: an empirical approach to medical decision making in neonatal intensive care. JAMA1987; 258 (14):1929–1931.
7.
LoganRL, ScottPJ. Uncertainty in clinical practice: implications for quality and costs of health care. Lancet1996; 347: 595–598.
8.
RizzoJA. Physician uncertainty and the art of persuasion. Soc Sci Med1993; 37 (12):1451–1459.
9.
RhodenNK. Treating Baby Doe: the ethics of uncertainty. Hastings Center Report1986; 16: 34–42.
10.
VersluysC.To do or not to do: the ethics of neonatal care. In: BurgioGR, LantosJD (eds). Primum Non Nocere Today, A Symposium on Pediatric Bioethics. New York: Elsevier, 1994; 51–65.
11.
Hastings Center Project on Imperiled Newborns.Anonymous. Section 2: The effect of new pediatric capabilities and the problem of uncertainty. Hastings Center Report 1987; 17 (6):10–13.
12.
StinsonR, StinsonP.The Long Dying of Baby Andrew. Boston: Little, Brown & Co., 1992.
13.
LantosJD, TysonJE, AllenA, FraderJ, HackM, KoronesS, Merenstein, PanethN, PolandRL, SaigalS, StevensonD, TruogRD, Van MarterLJ. Withholding and withdrawing life-sustaining treatment in neonatal intensive care: issues for the 1990s. Arch Dis Child1994; 71: F218–F223.
14.
DoyalL, WilsherD.Towards guidelines for withholding and withdrawal of life-prolonging treatment in neonatal medicine. Arch Dis Child1994; 70: F66–F70.
15.
Bioethics Committee, Canadian Paediatric Society.Can Med Assoc J1986; 135: 447–448.
16.
KopelmanLM, IronsTG, KopelmanAE. Neonatologists judge the “Baby Doe” regulations. N Engl J Med1988; 318 (11):677–683.
17.
NelsonLJ. Forgoing treatment of critically ill newborns and the legal legacy of Baby Doe. Clin Ethics Rep1992; 6 (2):1–6.
18.
LantosJ.Baby Doe five years later: Implications for child health. N Engl J Med1987; 317 (7):444–447.
19.
SlevinML, PlantH, LynchD, DrinkwaterJ, GregoryWM. Who should measure quality of life, the patient or the doctor? Brit J Canc1988; 57 (1):109–112.
20.
CassellEJ. The nature of suffering and the goals of medicine. N Engl J Med1982; 306 (11):639–645.
21.
LeikinSL. Risks of research on children. J Peds1982; 100: 166.
22.
RobertsE.Refusal of treatment by 16 year old. Lancet1992; 22, pt 2: 502–507.
23.
GamulkaBD. Ethical uncertainty: an approach to decisions involving extracorporeal membrane oxygenation. Can Med Assoc J1994; 150 (4):565–568.
24.
Bluebond-LangnerM.The Private Worlds of Dying Children. Princeton: Princeton University Press, 1978.
25.
SusmanEJ, HershSP, NannisED, . Conceptions of cancer; the perspectives of child and adolescent patients and their families. J Ped Psych1982; 7 (3):253–261.
26.
LeikinSL. The role of adolescents in decisions concerning their cancer therapy. Can Suppl1993; 71 (10):3342–3346.
27.
BartholomeWG. A new understanding of consent in pediatric practice: consent, parental permission and assent. Ped Annals1989; 18 (4):262–265.
28.
FreyerDR. Children with cancer: special considerations in the discontinuation of life-sustaining treatment. J Med Ped Oncol1992; 20: 136–142.
29.
KingNMP, CrossAW. Children as decision-makers: guidelines for pediatricians. J Peds1989; 115 (1):10–16.
30.
DoyalL, HenningP.Stopping treatment for end-stage renal failure: the rights of children and adolescents. J Ped Neph1994; 8: 768–791.
31.
Committee on Bioethics, American Academy of Pediatrics. Informed consent, parental permission and assent in pediatric practice. Pediatrics1995; 95 (2):314–317.
32.
LeikinS.A proposal concerning decisions to forgo life-sustaining treatment for young people. J Peds1989; 115 (1):17–22.
33.
FeegVD. Ethics lessons in a teenager's story. Ped Nurs1994; 20 (5):436.
34.
GrissoT, VierlingL.Minors’ consent to treatment: a developmental perspective. Prof Psychol1978; 9 (3):412–427.
35.
RushtonCH. Commentary: guidelines on forgoing life-sustaining medical treatment. Ped Nurs1994; 20 (5):522.
36.
DraneJF. Competency to give an informed consent: a model for making clinical assessments. JAMA1984; 252 (7):925–927.
37.
Committee on Bioethics, American Academy of Pediatrics. Guidelines on forgoing life-sustaining medical treatment. Pediatrics1994; 93 (3):532–536.
38.
JonsenAR. Research involving children: recommendations of the national commission for the protection of human subjects of biomedical and behavioral research. Pediatrics1978; 62 (2):131–136.
39.
TysonJ.Evidence-based ethics and the care of premature infants. The Future of Children1995; 5 (1):197–221.
40.
TysonJ.The boundary between therapeutic and non-therapeutic research. In: GoldworthA, SilvermanW, StevensonDK, YoungEWD, RiversR.Ethics and Perinatology. New York: Oxford University Press, 1995; 214–230.
41.
American Academy of Pediatrics, Committee on Drugs. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics1977; 60 (1):91–101.
42.
JanofskyJ, StarfieldB.Assessment of risk in research on children. J Peds1981; 98 (5):842–846.
43.
KingNMP. Experimental treatment: oxymoron or aspiration? Hastings Center Report1995; 25 (4):6–15.
44.
O'RourkePP, CroneRK, VacantiJP, WareJH, LillehiCW, ParadRB, EpsteinMF. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics1989; 84: 957–963.
45.
KnoxRA. A Harvard study on newborns draws fire. Doctors faulted for limiting life-saving treatment. Boston Globe, Monday, August 7, 1989, Third Section: Science and Technology, p. 25.
46.
NitschkeR, HumphreyGB, SexauerCL, CatronB, WunderS, JayS.Therapeutic choices made by patients with end-stage cancer. J Peds1982; 101 (3):471–476.
47.
ApplebaumPS, RothLH, LidzCW, BensonP, WinsladeW.False hopes and best data: consent to research and the therapeutic misconception. Hastings Center Report1987; 17 (2):20–24.